NeoManna is focused on addressing the global challenges and pitfalls of Anti-Microbial Resistance (AMR). NeoManna specializes in developing, manufacturing and selling novel, natural anti-microbial and anti-inflammatory products that successfully combat the overuse of antibiotics in livestock, aquaculture, and companion animals. The company's innovative CAPEX-free model and groundbreaking R&D in Black Soldier Fly (BSF) originates bioactives, already provide high-volume, competitively priced modified BSF ingredients incorporated into both liquid animal nutrition and solid animal nutrition, thereby reducing production costs, improving EBITDA and safeguarding the global food value chain severely impacted by the combination of climate change and globalization withdrawal. NeoManna is an AgChimedes Group company.